Polymorphism & Patenting for Pharmaceutical Applications - April 26-27, 2005 Germany

Polymorphism & Patenting for Pharmaceutical Applications
April 26-27, 2005 Germany
Hotel Maritim, Munich, Germany
Benefits of Attending:
Why should I attend?
The analysis and design of polymorphs as well as their patenting are substantial steps within the production of new medicines. Our congress will focus on these subjects. You will learn about crystal design as well as the selection and stability of polymorphs and thus get an overview of the basics and the current level of pharmaceutical research. An additional topic will be the analysis and screening technology. Profit from the special focus on patenting and jurisdiction and hear the latest updates e.g. about legal and commercial aspects of the Supplementary Protection Certificate (SPC) for Pharmaceuticals.
Who will I meet and who is speaking?
Profit from the experience and knowledge of revealing academic institutes and companies like:
Bayer HealthCare AG, Solvias AG, CSIC-University of Granada, European Patent Office, University of Bradford, Avantium Technologies, Merck KGaA
Don't miss this event because...
it offers a great opportunity to learn about both - the pharmaceutical research and technology and the patent issues involved in polymorphism like SPC (Supplementary Protection Certificate) and the ?problem?and-solution approach? adopted by the European Patent Office.